Medications

1st drug for tardive dyskinesia approved

(HealthDay)—Ingrezza (valbenazine), the first drug to treat adults with the neurological disorder tardive dyskinesia, has been approved by the U.S. Food and Drug Administration.

Cardiology

Head off 'holiday heart syndrome'

(HealthDay)—Overindulging over the holidays can take a toll on the heart, according to experts at UT Southwestern Medical Center in Dallas.

page 12 from 30